Pfizer’s move to cut taxes makes sense: Your Say

U.S.-based pharmaceutical company Pfizer and Ireland-based Allergan announced they are merging in a deal worth $160 billion. Comments from Facebook are edited for clarity and grammar:

Pfizer needs to be broken up to make the price of drugs more competitive, rather than allowing it to merge with another huge company. The free market works if there is healthy competition. A merger like this one is the antithesis of a free market.

— Nita Sainju

The government needs to stay out of the way of private enterprise. Why should the government control who merges with whom? Is the next step going to be telling these companies what medications they can and can’t work on producing?

When government starts dictating to business, then it is downhill all the way.

— Larry Hubble

Why do you think companies are leaving America? Democrats are driving them out with taxes and overregulation.

— Chad Clausen

POLICING THE USA: A look at race, justice, media

Regulation ensures the protection of the populace from immoral, predatory businesses, which is the proper role of a well-functioning government.

— Michael Bender

Pfizer wants the benefits of doing business in the U.S., but it just doesn’t want to help pay for it. This deal, known as a tax inversion, will allow Pfizer to reincorporate in a foreign country and cut its future tax bills.

— Sam Taylor

Why is the deal a surprise? This tax inversion will save the combined company a lot of money. It is only doing what the tax code is telling it to do.

— David Norris